Figures & data
Table 1. Description of study site characteristics and environmental exposures
Table 2. Characteristics chronic bronchitis and non-chronic bronchitis in 2947 subjects
Table 3. Characteristics of chronic bronchitis vs. non-chronic bronchitis among participants with chronic obstructive pulmonary disease (post-bronchodilator FEV1/FVC <LLN)
Table 4. Measured exposures and respiratory disease prevalence by study site
Figure 1. Differences in prevalence of COPD (defined as post-bronchodilator FEV1/FVC < LLN) and chronic bronchitis (defined as phlegm production for ≥ 3 months in 2 successive years) stratified by site.
![Figure 1. Differences in prevalence of COPD (defined as post-bronchodilator FEV1/FVC < LLN) and chronic bronchitis (defined as phlegm production for ≥ 3 months in 2 successive years) stratified by site.](/cms/asset/8cf743e9-ed9d-4270-ad81-9687d76c6637/icop_a_1067765_f0001_c.jpg)
Table 5. Post-bronchodilator lung function values stratified by disease phenotype
Table 6. Single and multivariable regression of factors associated with prevalence of chronic bronchitis in Peru